Results 151 to 160 of about 14,076 (220)

uPAR-Guided Dendrimer Gel Nanoparticles Reprogram Inflammation to Stabilize Atherosclerotic Plaques. [PDF]

ACS Appl Mater Interfaces
Chuang HY, Kou H, Huang YW, Yang H.
europepmc   +1 more source

Cholecystokinin A Receptor Knockdown Diminishes Colon Cancer Cell Invasive Potential via Modulation of Integrin/FAK, EMT, and uPA/uPAR/MMP2 Axis. [PDF]

Oncol Res
Lin CS, Hsu TW, Lee HL, Kao SH.
europepmc   +1 more source

Vasculogenic Mimicry: A Potential Therapeutic Target for Chondrosarcoma Therapy. [PDF]

Cells
Ingangi V, Gatti R, Di Carluccio G, Di Vaia V, Cerrone M, Ferrara G, Scala S, Maddalena M, Gallo M, Fazioli F, Ciardiello C, Minopoli M, Carriero MV.   +12 more
europepmc   +1 more source

Plasminogen activator inhibitor-1 as an oncologic target: biology, therapeutic inhibitors, and clinical translation. [PDF]

Front Oncol
Al Shaer NSH, Tleyjeh A, Al-Attas MA, Alibrahim JH, Khan MI, Yaqinuddin A.   +5 more
europepmc   +1 more source

Plasminogen Activator Inhibitor-1 is Internalized by Endothelial Cells via A Pinocytosis-Like Mechanism and Evades Degradation. [PDF]

FASEB J
McAdow M, Ahmetaj G, Hauschel R, Eichmann A, Sessa W.   +4 more
europepmc   +1 more source

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. [PDF]

Neuromolecular Med
de Rezende VL, Mathias K, Danielski LG, Barichello T, Petronilho F.   +4 more
europepmc   +1 more source

Differentiating borderline HER2-expressing and HER2-positive cancers from other subtypes using serum urokinase plasminogen activator. [PDF]

Br J Cancer
López Mujica MEJ, Boonkaew S, Christensen NL, Abildgaard Pedersen M, Riegels Jørgensen K, Holm Vendelbo M, Ferapontova EE.   +6 more
europepmc   +1 more source

Correction: The receptor for urokinaseplasminogen activator uPAR controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. [PDF]

Oncotarget
Margheri F, Luciani C, Taddei ML, Giannoni E, Laurenzana A, Biagioni A, Chill xE A, Chiarugi P, Fibbi G, Rosso MD.   +9 more
europepmc   +1 more source

The role of suPAR and related proteins in kidney, heart diseases, and diabetes. [PDF]

J Clin Invest
Reiser J, Hayek SS, Sever S.
europepmc   +1 more source

From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer. [PDF]

Sci Rep
Badukle H, Jawarkar RD, Shah U, Chaudhary S, Alzahrani AYA, Samad A, Al-Hussain SA, Al-Mutairi AA, Zaki MEA.   +8 more
europepmc   +1 more source